Nadolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FEN504330V. European Medicines Agency schedules Nadolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09111MIG. Nadolol generally arises in the molecular formula C17H27NO4. The term NADOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, no. 10 1979, list 19.) NADOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nadolol under HS 29221980 and SITC 51461. As of Q4 2014, NADOLOL remains the US FDA Preferred Term for this commodity. Nadolol bears US NLM identifiers UMLS ID C0027302 and NCI Concept Code C29280. SMILES: CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O.